BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, Cai W, Ma Y, Ren D, Miao J, Chen S, Zhang Z, Chen J, Zhong J, Liu W, Zou M, Li Y, Cai J. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome 2018;6:66. [PMID: 29615110 DOI: 10.1186/s40168-018-0441-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou W, Cheng Y, Zhu P, Nasser MI, Zhang X, Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5394096. [PMID: 33062141 DOI: 10.1155/2020/5394096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Boccella N, Paolillo R, Coretti L, D'Apice S, Lama A, Giugliano G, Schiattarella GG, Cuomo M, d'Aquino I, Cavaliere G, Paciello O, Mollica MP, Mattace Raso G, Esposito G, Lembo F, Perrino C. Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation. Sci Rep 2021;11:7404. [PMID: 33795775 DOI: 10.1038/s41598-021-86651-y] [Reference Citation Analysis]
3 Andrei S, Nguyen M, Berthoud V, Morgant MC, Bouhemad B, Guinot PG; ECMORIX Study Group. Evaluation of the Oxiris Membrane in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support: Study Protocol for a Single Center, Single-Blind, Randomized Controlled Trial. Front Cardiovasc Med 2021;8:738496. [PMID: 34708091 DOI: 10.3389/fcvm.2021.738496] [Reference Citation Analysis]
4 Carnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, Frati G, Forte M, d'Amati G, Pignataro MG, Severino A, Cangemi R, Arrivi A, Dominici M, Mangieri E, Gaudio C, Tanzilli G, Violi F. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J 2020;41:3156-65. [PMID: 31898723 DOI: 10.1093/eurheartj/ehz893] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
5 Li C, Xiao P, Lin D, Zhong HJ, Zhang R, Zhao ZG, He XX. Risk Factors for Intestinal Barrier Impairment in Patients With Essential Hypertension. Front Med (Lausanne) 2020;7:543698. [PMID: 33585498 DOI: 10.3389/fmed.2020.543698] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cheng P, Lian FZ, Wang XY, Cai GW, Huang GY, Chen ML, Shen AZ, Gao S. Xin-Ji-Er-Kang Alleviates Myocardial Infarction-Induced Cardiovascular Remodeling in Rats by Inhibiting Endothelial Dysfunction. Biomed Res Int 2019;2019:4794082. [PMID: 31341899 DOI: 10.1155/2019/4794082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Li Q, Gao B, Siqin B, He Q, Zhang R, Meng X, Zhang N, Zhang N, Li M. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids. Front Pharmacol 2021;12:651926. [PMID: 34220497 DOI: 10.3389/fphar.2021.651926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Jia Q, Xie Y, Lu C, Zhang A, Lu Y, Lv S, Zhang J. Endocrine organs of cardiovascular diseases: Gut microbiota. J Cell Mol Med 2019;23:2314-23. [PMID: 30688023 DOI: 10.1111/jcmm.14164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Xu R, Tan C, He Y, Wu Q, Wang H, Yin J. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study. Front Immunol 2020;11:1994. [PMID: 32973805 DOI: 10.3389/fimmu.2020.01994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xie Z, Liu X, Huang X, Liu Q, Yang M, Huang D, Zhao P, Tian J, Wang X, Hou J. Remodelling of gut microbiota by Berberine attenuates trimethylamine N-oxide-induced platelet hyperreaction and thrombus formation. Eur J Pharmacol 2021;911:174526. [PMID: 34599914 DOI: 10.1016/j.ejphar.2021.174526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mousa WK, Chehadeh F, Husband S. Recent Advances in Understanding the Structure and Function of the Human Microbiome. Front Microbiol 2022;13:825338. [DOI: 10.3389/fmicb.2022.825338] [Reference Citation Analysis]
12 Murphy K, O'Donovan AN, Caplice NM, Ross RP, Stanton C. Exploring the Gut Microbiota and Cardiovascular Disease. Metabolites 2021;11:493. [PMID: 34436434 DOI: 10.3390/metabo11080493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu DJ, Wang KC, Yuan LB, Li HF, Xu YY, Wei LY, Chen L, Jin KK, Lin QQ. Compositional and functional alterations of gut microbiota in patients with stroke. Nutr Metab Cardiovasc Dis 2021;31:3434-48. [PMID: 34666915 DOI: 10.1016/j.numecd.2021.08.045] [Reference Citation Analysis]
14 Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, Liu C, He K, Sun Z. Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. Cell Signal 2019;53:1-13. [PMID: 30219671 DOI: 10.1016/j.cellsig.2018.09.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
15 Zhang Y, Xu J, Wang X, Ren X, Liu Y. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. BMC Genomics 2019;20:862. [PMID: 31726978 DOI: 10.1186/s12864-019-6251-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
16 Liu Z, Li N, Fang H, Chen X, Guo Y, Gong S, Niu M, Zhou H, Jiang Y, Chang P, Chen P. Enteric dysbiosis is associated with sepsis in patients. FASEB J 2019;33:12299-310. [PMID: 31465241 DOI: 10.1096/fj.201900398RR] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Lagos L, Leanti La Rosa S, Ø Arntzen M, Ånestad R, Terrapon N, Gaby JC, Westereng B. Isolation and Characterization of Extracellular Vesicles Secreted In Vitro by Porcine Microbiota. Microorganisms 2020;8:E983. [PMID: 32630095 DOI: 10.3390/microorganisms8070983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines 2022;10:948. [DOI: 10.3390/biomedicines10050948] [Reference Citation Analysis]
19 Jia Q, Li H, Zhou H, Zhang X, Zhang A, Xie Y, Li Y, Lv S, Zhang J. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure. Cardiovasc Ther 2019;2019:5164298. [PMID: 31819762 DOI: 10.1155/2019/5164298] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
20 Velmurugan G, Dinakaran V, Rajendhran J, Swaminathan K. Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease. Trends Endocrinol Metab 2020;31:835-47. [PMID: 33086076 DOI: 10.1016/j.tem.2020.01.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
21 McCarthy CG, Saha P, Golonka RM, Wenceslau CF, Joe B, Vijay-Kumar M. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs). Compr Physiol 2021;11:1575-89. [PMID: 33577121 DOI: 10.1002/cphy.c200020] [Reference Citation Analysis]
22 Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, Qin Y, Liu X, Li S, Cai J, Zhong J, Yang X. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience 2019;8:giz058. [PMID: 31149718 DOI: 10.1093/gigascience/giz058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
23 Zhu W, Peng F, Cui X, Li J, Sun C. LncRNA SOX2OT facilitates LPS-induced inflammatory injury by regulating intercellular adhesion molecule 1 (ICAM1) via sponging miR-215-5p. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109006] [Reference Citation Analysis]
24 Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, Wang S, Xin H. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr 2022;:e0107721. [PMID: 35384710 DOI: 10.1128/spectrum.01077-21] [Reference Citation Analysis]
25 Tian B, Zhao J, An W, Zhang J, Cao X, Mi J, Zhao J, Zhang Y, Li J. Lycium ruthenicum diet alters the gut microbiota and partially enhances gut barrier function in male C57BL/6 mice. Journal of Functional Foods 2019;52:516-28. [DOI: 10.1016/j.jff.2018.11.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
26 Sim JH, Mukerji SS, Russo SC, Lo J. Gastrointestinal Dysfunction and HIV Comorbidities. Curr HIV/AIDS Rep 2021;18:57-62. [PMID: 33469815 DOI: 10.1007/s11904-020-00537-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang X, Dong S, Jia Q, Zhang A, Li Y, Zhu Y, Lv S, Zhang J. The microRNA in ventricular remodeling: the miR-30 family. Biosci Rep 2019;39:BSR20190788. [PMID: 31320543 DOI: 10.1042/BSR20190788] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
28 Crowley EK, Long-Smith CM, Murphy A, Patterson E, Murphy K, O'Gorman DM, Stanton C, Nolan YM. Dietary Supplementation with a Magnesium-Rich Marine Mineral Blend Enhances the Diversity of Gastrointestinal Microbiota. Mar Drugs 2018;16:E216. [PMID: 29925774 DOI: 10.3390/md16060216] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
29 Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I. Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population. Atherosclerosis 2019;286:53-9. [PMID: 31100620 DOI: 10.1016/j.atherosclerosis.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 Bai H, Gu RJ, Chen LY, Qian Y, Yu ML, Xu SL, Xia XF, Liu YC, Zhang HR, Gu YH, Lu SF. Electroacupuncture interventions alleviates myocardial ischemia reperfusion injury through regulating gut microbiota in rats. Microvasc Res 2021;138:104235. [PMID: 34453991 DOI: 10.1016/j.mvr.2021.104235] [Reference Citation Analysis]
31 Liu L, He X, Feng Y. Coronary heart disease and intestinal microbiota. Coron Artery Dis 2019;30:384-9. [PMID: 31276455 DOI: 10.1097/MCA.0000000000000758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 László SB, Lázár B, Brenner GB, Makkos A, Balogh M, Al-Khrasani M, Hutka B, Mohammadzadeh A, Kemény Á, László T, Scheich B, Szabados T, Kenyeres É, Giricz Z, Bencsik P, Varga ZV, Novák J, Helyes Z, Ferdinandy P, Gyires K, Zádori ZS. Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats. Biochem Pharmacol 2020;178:114099. [PMID: 32540483 DOI: 10.1016/j.bcp.2020.114099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol 2020;319:H1227-33. [PMID: 32986965 DOI: 10.1152/ajpheart.00612.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Huo JY, Jiang WY, Yin T, Xu H, Lyu YT, Chen YY, Chen M, Geng J, Jiang ZX, Shan QJ. Intestinal Barrier Dysfunction Exacerbates Neuroinflammation via the TLR4 Pathway in Mice With Heart Failure. Front Physiol 2021;12:712338. [PMID: 34421655 DOI: 10.3389/fphys.2021.712338] [Reference Citation Analysis]
35 Zuo K, Liu X, Wang P, Jiao J, Han C, Liu Z, Yin X, Li J, Yang X. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients. BMC Genomics 2020;21:526. [PMID: 32731896 DOI: 10.1186/s12864-020-06944-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Qi D, Nie XL, Zhang JJ. The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis. Lipids Health Dis 2020;19:79. [PMID: 32334580 DOI: 10.1186/s12944-020-01259-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
37 Li Q, Xu T, Zhong H, Gao W, Shao C, Feng L, Li T. Impaired intestinal barrier in patients with obstructive sleep apnea. Sleep Breath 2021;25:749-56. [PMID: 32845474 DOI: 10.1007/s11325-020-02178-y] [Reference Citation Analysis]
38 Zhou X, Yang Q. From hemorrhagic stroke to lipid paradox: a double-hit hypothesis underlying low low-density lipoprotein cholesterol related cardiovascular risk—a narrative review. Journal of Bio-X Research 2020;3:97-103. [DOI: 10.1097/jbr.0000000000000067] [Reference Citation Analysis]
39 Khan I, Khan I, Jianye Z, Xiaohua Z, Khan M, Hilal MG, Kakakhel MA, Mehmood A, Lizhe A, Zhiqiang L. Exploring blood microbial communities and their influence on human cardiovascular disease. J Clin Lab Anal 2022;:e24354. [PMID: 35293034 DOI: 10.1002/jcla.24354] [Reference Citation Analysis]
40 Chen R, Li W, Qiu Z, Zhou Q, Zhang Y, Li WY, Ding K, Meng QT, Xia ZY. Ischemic Postconditioning-Mediated DJ-1 Activation Mitigate Intestinal Mucosa Injury Induced by Myocardial Ischemia Reperfusion in Rats Through Keap1/Nrf2 Pathway. Front Mol Biosci 2021;8:655619. [PMID: 33996908 DOI: 10.3389/fmolb.2021.655619] [Reference Citation Analysis]
41 Zuo K, Li J, Wang P, Liu Y, Liu Z, Yin X, Liu X, Yang X. Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes. mSystems 2019;4:e00422-19. [PMID: 31822598 DOI: 10.1128/mSystems.00422-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
42 Hu C, Wang P, Yang Y, Li J, Jiao X, Yu H, Wei Y, Li J, Qin Y. Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota. Front Cell Infect Microbiol 2021;11:560201. [PMID: 34277461 DOI: 10.3389/fcimb.2021.560201] [Reference Citation Analysis]
43 Cookson TA. Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut. Front Cardiovasc Med 2021;8:721393. [PMID: 34485420 DOI: 10.3389/fcvm.2021.721393] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Filosa A, Sawamiphak S. Heart development and regeneration-a multi-organ effort. FEBS J 2021. [PMID: 34894086 DOI: 10.1111/febs.16319] [Reference Citation Analysis]
45 Gao J, Wang J, Zhao LL, Yao TT, Chen Y, Ma J, Zhang X, Wang JX, Wang Y, Cui Z, Liu Y. Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome. Front Cell Infect Microbiol 2021;11:687827. [PMID: 34557424 DOI: 10.3389/fcimb.2021.687827] [Reference Citation Analysis]
46 Zhang X, Wang Y, Liu W, Wang T, Wang L, Hao L, Ju M, Xiao R. Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population. Am J Clin Nutr 2021;114:429-40. [PMID: 33871591 DOI: 10.1093/ajcn/nqab078] [Reference Citation Analysis]
47 Shao C, Li Y, Chen J, Zheng L, Chen W, Peng Q, Chen R, Yuan A. Physical Exercise Repairs Obstructive Jaundice-Induced Damage to Intestinal Mucosal Barrier Function via H2S-Mediated Regulation of the HMGB1/Toll Like Receptors 4/Nuclear Factor Kappa B Pathway. Front Physiol 2022;12:732780. [DOI: 10.3389/fphys.2021.732780] [Reference Citation Analysis]
48 Zuurbier CJ, Abbate A, Cabrera-Fuentes HA, Cohen MV, Collino M, De Kleijn DPV, Downey JM, Pagliaro P, Preissner KT, Takahashi M, Davidson SM. Innate immunity as a target for acute cardioprotection. Cardiovasc Res 2019;115:1131-42. [PMID: 30576455 DOI: 10.1093/cvr/cvy304] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 27.0] [Reference Citation Analysis]
49 Gao J, Yan KT, Wang JX, Dou J, Wang J, Ren M, Ma J, Zhang X, Liu Y. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Sci Rep 2020;10:2639. [PMID: 32060329 DOI: 10.1038/s41598-020-59235-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
50 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
51 Aguirre García MM, Mancilla-galindo J, Paredes-paredes M, Tiburcio ÁZ, Ávila-vanzzini N. Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome. Future Virology 2021;16:43-57. [DOI: 10.2217/fvl-2020-0310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
52 Marras L, Caputo M, Bisicchia S, Soato M, Bertolino G, Vaccaro S, Inturri R. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. Microorganisms 2021;9:836. [PMID: 33919907 DOI: 10.3390/microorganisms9040836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Sadgrove NJ, Padilla-González GF, Leuner O, Melnikovova I, Fernandez-Cusimamani E. Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis. Front Pharmacol 2021;12:740302. [PMID: 34744723 DOI: 10.3389/fphar.2021.740302] [Reference Citation Analysis]
54 Goswami SK, Ranjan P, Dutta RK, Verma SK. Management of inflammation in cardiovascular diseases. Pharmacol Res 2021;173:105912. [PMID: 34562603 DOI: 10.1016/j.phrs.2021.105912] [Reference Citation Analysis]
55 Yang L, Wang T, Zhang X, Zhang H, Yan N, Zhang G, Yan R, Li Y, Yu J, He J, Jia S, Wang H. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis. BMC Cardiovasc Disord 2022;22:61. [PMID: 35172728 DOI: 10.1186/s12872-022-02508-w] [Reference Citation Analysis]
56 Xu R, Wu B, Liang J, He F, Gu W, Li K, Luo Y, Chen J, Gao Y, Wu Z, Wang Y, Zhou W, Wang M. Altered gut microbiota and mucosal immunity in patients with schizophrenia. Brain Behav Immun 2020;85:120-7. [PMID: 31255682 DOI: 10.1016/j.bbi.2019.06.039] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 13.3] [Reference Citation Analysis]
57 Dong S, Ji W, Zeng S, Miao J, Yan L, Liu X, Liu J, Zhou X, Yang Q. Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised. J of Cardiovasc Trans Res 2020;13:916-27. [DOI: 10.1007/s12265-020-10015-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhao X, Zeng H, Lei L, Tong X, Yang L, Yang Y, Li S, Zhou Y, Luo L, Huang J, Xiao R, Chen J, Zeng Q. Tight junctions and their regulation by non-coding RNAs. Int J Biol Sci 2021;17:712-27. [PMID: 33767583 DOI: 10.7150/ijbs.45885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
59 Trøseid M, Andersen GØ, Broch K, Hov JR. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine 2020;52:102649. [PMID: 32062353 DOI: 10.1016/j.ebiom.2020.102649] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
60 Zuo K, Yin X, Li K, Zhang J, Wang P, Jiao J, Liu Z, Liu X, Liu J, Li J, Yang X. Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis. mSphere 2020;5:e00071-20. [PMID: 32188747 DOI: 10.1128/mSphere.00071-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
61 Xu J, Yang Y. Implications of gut microbiome on coronary artery disease. Cardiovasc Diagn Ther 2020;10:869-80. [PMID: 32968642 DOI: 10.21037/cdt-20-428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zhang X, Zhang X, Tong F, Cai Y, Zhang Y, Song H, Tian X, Yan C, Han Y. Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment. Elife 2022;11:e70240. [PMID: 35258452 DOI: 10.7554/eLife.70240] [Reference Citation Analysis]
63 El Moheb M, Jia Z, Qin H, El Hechi MW, Nordestgaard AT, Lee JM, Han K, Kaafarani HMA. The Obesity Paradox in Elderly Patients Undergoing Emergency Surgery: A Nationwide Analysis. J Surg Res 2021;265:195-203. [PMID: 33951584 DOI: 10.1016/j.jss.2021.02.008] [Reference Citation Analysis]
64 Piccioni A, de Cunzo T, Valletta F, Covino M, Rinninella E, Raoul P, Zanza C, Mele MC, Franceschi F. Gut Microbiota and Environment in Coronary Artery Disease. Int J Environ Res Public Health 2021;18:4242. [PMID: 33923612 DOI: 10.3390/ijerph18084242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Du X, Zhang J, Zhang X, Schramm KW, Nan B, Huang Q, Tian M, Shen H. Persistence and reversibility of arsenic-induced gut microbiome and metabolome shifts in male rats after 30-days recovery duration. Sci Total Environ 2021;776:145972. [PMID: 33647652 DOI: 10.1016/j.scitotenv.2021.145972] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Zeng C, Tan H. Gut Microbiota and Heart, Vascular Injury. Adv Exp Med Biol 2020;1238:107-41. [PMID: 32323183 DOI: 10.1007/978-981-15-2385-4_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Xiao S, Xue T, Pan Q, Hu Y, Wu Q, Liu Q, Wang X, Liu A, Liu J, Zhu H, Zhou Y, Pan D. MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction. Cardiovasc Ther 2021;2021:2923441. [PMID: 34786024 DOI: 10.1155/2021/2923441] [Reference Citation Analysis]
68 Huo JY, Jiang WY, Lyu YT, Zhu L, Liu HH, Chen YY, Chen M, Geng J, Jiang ZX, Shan QJ. Renal Denervation Attenuates Neuroinflammation in the Brain by Regulating Gut-Brain Axis in Rats With Myocardial Infarction. Front Cardiovasc Med 2021;8:650140. [PMID: 33981735 DOI: 10.3389/fcvm.2021.650140] [Reference Citation Analysis]
69 Zhu L, Ye C, Hu B, Xia H, Bian Q, Liu Y, Kong M, Zhou S, Liu H. Regulation of gut microbiota and intestinal metabolites by Poria cocos oligosaccharides improves glycolipid metabolism disturbance in high-fat diet-fed mice. The Journal of Nutritional Biochemistry 2022. [DOI: 10.1016/j.jnutbio.2022.109019] [Reference Citation Analysis]
70 Kwun JS, Kang SH, Lee HJ, Park HK, Lee WJ, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH. Comparison of thrombus, gut, and oral microbiomes in Korean patients with ST-elevation myocardial infarction: a case-control study. Exp Mol Med 2020;52:2069-79. [PMID: 33339953 DOI: 10.1038/s12276-020-00543-1] [Reference Citation Analysis]
71 Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X, Yang R, Jiang R, Xu Y, Qin H. Dysbiosis signatures of gut microbiota in coronary artery disease. Physiological Genomics 2018;50:893-903. [DOI: 10.1152/physiolgenomics.00070.2018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
72 Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L, Cai J. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell 2021;12:346-59. [PMID: 32989686 DOI: 10.1007/s13238-020-00785-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Kruglikov IL, Shah M, Scherer PE. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions. Elife 2020;9:e61330. [PMID: 32930095 DOI: 10.7554/eLife.61330] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]